Resensitization of cisplatin resistance ovarian cancer cells to cisplatin through pretreatment with low‐dose fraction radiation

OBJECTIVE: Cisplatin is the first‐line chemotherapy for ovarian cancer. However, cisplatin resistance is severely affecting the treatment efficacy. FOXO3a has been reported to be involved in reversing chemotherapy resistance. However, whether low‐dose fraction radiation therapy (LDFRT) can reverse c...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Lili, Liu, Shihai, Liang, Donghai, Jiang, Tao, Yan, Xiaoyan, Zhao, Shengnan, Liu, Yuanwei, Zhao, Wei, Yu, Hongsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536942/
https://www.ncbi.nlm.nih.gov/pubmed/30941896
http://dx.doi.org/10.1002/cam4.2116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536942/
https://www.ncbi.nlm.nih.gov/pubmed/30941896
http://dx.doi.org/10.1002/cam4.2116

Ejemplares similares